Cambridge Investment Research Advisors
THQ

Cambridge Investment Research Advisors’s abrdn Healthcare Opportunities Fund THQ Stock Holding History

Cambridge Investment Research Advisors’s Portfolio THQ Stock Details THQ Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1M Sell
53,521
-571
-1% -$10.4K ﹤0.01% 2320
2026
Q1 		$909K Buy
54,092
+4,713
+10% +$88.6K ﹤0.01% 2256
2025
Q4 		$945K Sell
49,379
-581
-1% -$10.7K ﹤0.01% 2141
2025
Q3 		$864K Buy
49,960
+1,842
+4% +$31.4K ﹤0.01% 2165
2025
Q2 		$885K Sell
48,118
-21,698
-31% -$403K ﹤0.01% 2048
2025
Q1 		$1.44M Sell
69,816
-2,379
-3% -$48.6K ﹤0.01% 1582
2024
Q4 		$1.36M Buy
72,195
+3,871
+6% +$80K ﹤0.01% 1632
2024
Q3 		$1.51M Sell
68,324
-801
-1% -$17.1K 0.01% 1561
2024
Q2 		$1.41M Buy
69,125
+4,134
+6% +$82.2K 0.01% 1534
2024
Q1 		$1.31M Buy
64,991
+7,713
+13% +$148K 0.01% 1552
2023
Q4 		$1.04M Sell
57,278
-2,982
-5% -$50.4K ﹤0.01% 1636
2023
Q3 		$1.02M Buy
60,260
+1,126
+2% +$20.9K ﹤0.01% 1569
2023
Q2 		$1.13M Sell
59,134
-876
-1% -$16.5K 0.01% 1523
2023
Q1 		$1.13M Buy
60,010
+112
+0.2% +$2.14K 0.01% 1499
2022
Q4 		$1.19M Buy
59,898
+1,331
+2% +$26.3K 0.01% 1396
2022
Q3 		$1.06M Sell
58,567
-8,360
-12% -$167K 0.01% 1431
2022
Q2 		$1.33M Buy
66,927
+47
+0.1% +$984 0.01% 1268
2022
Q1 		$1.49M Sell
66,880
-27,163
-29% -$607K 0.01% 1315
2021
Q4 		$2.41M Sell
94,043
-2,173
-2% -$52.2K 0.01% 1034
2021
Q3 		$2.18M Buy
96,216
+2,296
+2% +$55.3K 0.01% 1055
2021
Q2 		$2.17M Sell
93,920
-9,752
-9% -$224K 0.01% 1068
2021
Q1 		$2.25M Buy
103,672
+23,451
+29% +$492K 0.01% 947
2020
Q4 		$1.64M Buy
80,221
+11,525
+17% +$220K 0.01% 1034
2020
Q3 		$1.24M Sell
68,696
-7,683
-10% -$140K 0.01% 1060
2020
Q2 		$1.36M Buy
76,379
+43,193
+130% +$763K 0.01% 953
2020
Q1 		$510K Buy
33,186
+1,312
+4% +$23.1K ﹤0.01% 1356
2019
Q4 		$608K Buy
31,874
+410
+1% +$7.42K ﹤0.01% 1454
2019
Q3 		$549K Sell
31,464
-312
-1% -$5.47K ﹤0.01% 1440
2019
Q2 		$566K Buy
31,776
+5,322
+20% +$91.3K 0.01% 1350
2019
Q1 		$466K Buy
26,454
+8,003
+43% +$140K ﹤0.01% 1529
2018
Q4 		$310K Buy
18,451
+3,930
+27% +$69.7K ﹤0.01% 1644
2018
Q3 		$272K Buy
+14,521
New +$263K ﹤0.01% 1860

Other funds holding THQ

Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $672B AUM 33.48% 1-Year Est. Return
Raymond James Financial
Raymond James Financial St Petersburg, Florida $369B AUM 28.27% 1-Year Est. Return
HBCM
Heron Bay Capital Management Bloomfield Hills, Michigan $1.1B AUM 11.31% 1-Year Est. Return
PCM
Penserra Capital Management Orinda, California $13B AUM 71.84% 1-Year Est. Return
LPL Financial
LPL Financial San Diego, California $445B AUM 25.58% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $495B AUM 43.24% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return
WS
Wedbush Securities Los Angeles, California $3.88B AUM 32.38% 1-Year Est. Return
First Trust Advisors
First Trust Advisors Wheaton, Illinois $170B AUM 46.21% 1-Year Est. Return

Cambridge Investment Research Advisors's THQ Position: Q2 2026 in Review

Cambridge Investment Research Advisors reduced its abrdn Healthcare Opportunities Fund (THQ) stake by 1.1% in Q2 2026, selling an estimated $10.4K and leaving 53,521 shares worth $1M. The position accounts for ﹤0.01% of the portfolio, ranked #2320.

Cambridge Investment Research Advisors first reported a position in THQ in Q3 2018 and has held it in 32 quarters since. The position peaked at $2.41M in Q4 2021. 97 funds tracked by Wall St. Rank hold THQ as of Q2 2026.

  • Cambridge Investment Research Advisors held 53,521 shares of abrdn Healthcare Opportunities Fund worth $1M as of Q2 2026.
  • Cambridge Investment Research Advisors sold 571 abrdn Healthcare Opportunities Fund shares in Q2 2026, an estimated $10.4K.
  • abrdn Healthcare Opportunities Fund made up ﹤0.01% of Cambridge Investment Research Advisors's portfolio in Q2 2026, its #2320 holding.
  • Cambridge Investment Research Advisors first reported a position in abrdn Healthcare Opportunities Fund in Q3 2018 and has held it in 32 quarters since.
  • Cambridge Investment Research Advisors's abrdn Healthcare Opportunities Fund position peaked at $2.41M in Q4 2021.
  • 97 funds tracked by Wall St. Rank held abrdn Healthcare Opportunities Fund as of Q2 2026.

Based on Cambridge Investment Research Advisors's 13F filing for Q2 2026, filed 27 Jul 2026.